Patent details
EP3864014 Title: MALONATE SALT OF VARLITINIB
Basic Information
- Publication number:
- EP3864014
- PCT Application Number:
- SG2019050504
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP197908874
- PCT Publication Number:
- WO2020076239
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- MALONATE SALT OF VARLITINIB
- French Title of Invention:
- SEL DE MALONATE DE VARLITINIB
- German Title of Invention:
- MALONATSALZ VON VARLITINIB
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 04/08/2023
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 11/08/2023
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 05/07/2023
- Unitary Effect Registration Date:
- 11/08/2023
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 09/10/2019
- Grant date:
- 05/07/2023
- EP Publication Date:
- 18/08/2021
- PCT Publication Date:
- 16/04/2020
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 05/07/2023
- EP B1 Publication Date:
- 05/07/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 09/10/2039
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 11/08/2023
- Name:
- ASLAN Pharmaceuticals Pte Ltd
- Address:
- 3 Temasek Avenue N 18-01, Centennial Tower, Singapore 039190, Singapore (SG)
History of Owners
- From:
- 28/06/2023
- To:
- 11/08/2023
- Name:
- ASLAN Pharmaceuticals Pte Ltd
- Address:
- 83 Clemenceau Avenue, 12-03, UE Square 239920, Singapore (SG)
Inventor
- Name:
- MOORE, Robert
- Address:
- Singapore (SG)
Priority
- Priority Number:
- 10201808900X
- Priority Date:
- 09/10/2018
- Priority Country:
- Singapore (SG)
Classification
- IPC classification:
- C07D 417/14; A61K 31/517; A61P 35/00;
Publication
European Patent Bulletin
1
- Issue number:
- 202327
- Publication date:
- 05/07/2023
- Description:
- Grant (B1)
2
- Issue number:
- 202337
- Publication date:
- 13/09/2023
- Description:
- Change of owner's name or address
3
- Issue number:
- 202337
- Publication date:
- 13/09/2023
- Description:
- Unitary Effect Request Receipt
4
- Issue number:
- 202337
- Publication date:
- 13/09/2023
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|